Search

Search Results

• Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

  Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  12-11-2024

  https://doi.org/10.4081/dr.2024.10080

  1395

  PDF: 761

  HTML: 50

• Treatment satisfaction among patients with psoriasis in Saudi Arabia

  Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

  15-04-2024

  https://doi.org/10.4081/dr.2024.9967

  1139

  PDF: 658

  HTML: 52

• The top 100 most cited articles in acne vulgaris: a bibliometric analysis

  Sapir Itzhaki Gabay, Barak Zlakishvili, Yuliya Valdman-Grinshpoun , Amir Horev

  15-02-2024

  https://doi.org/10.4081/dr.2024.9886

  3370

  PDF: 618

  SUPPLEMENTARY MATERIAL: 204

  HTML: 26

• 26 | CONCOMITANT THERAPY WITH IXEKIZUMAB PLUS TIRZEPATIDE IN ADULTS WITH PSORIATIC ARTHRITIS AND OVERWEIGHT OR OBESITY DEMONSTRATED SUPERIOR DISEASE CONTROL COMPARED TO IXEKIZUMAB ALONE: RESULTS FROM THE PH3B TOGETHER-PSA TRIAL E. Filippi¹, J. F. Merola², P. Mease³, A. Kivitz⁴, N. Sattar⁵, L. C. Coates⁶, C. E. Kartman⁷, P. Fischer⁷, L. Sun⁷, A. Cardoso⁷, M. C. Genovese⁷, A. Ogdie⁸ | ¹Eli Lilly Italia S.p.A, Florence, Italy; ²Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; ³Providence Swedish Medical Center, Seattle, WA, USA; ⁴Altoona Center for Clinical Research, Duncansville, PA, USA; ⁵School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; ⁶Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; ⁷Eli Lilly and Company, Indianapolis, IN, USA; ⁸Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11088

  113

  PDF: 35

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  https://doi.org/10.4081/dr.2024.10140

  1101

  PDF: 583

  SUPPLEMENTARY MATERIAL: 189

  HTML: 24

• HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population

  Nhi Thi Uyen Pham, Thuong Van Nguyen, Hao Trong Nguyen

  16-10-2023

  https://doi.org/10.4081/dr.2023.9854

  1474

  PDF: 565

  HTML: 54
• 

  Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

  Federica Mola, Alberico Motolese

  e40

  03-10-2011

  https://doi.org/10.4081/dr.2011.e40

  1323

  PDF: 624

  HTML: 1093
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  https://doi.org/10.4081/dr.2023.9692

  1176

  PDF: 579

  HTML: 28
• 

  Acne exacerbation after tofacitinib treatment for alopecia areata

  Sawsan Alharthi, Mohammed G. Turkmani, Mohammed I. AlJasser

  01-01-2022

  https://doi.org/10.4081/dr.2022.9396

  2685

  PDF: 895

  HTML: 44
• 

  Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata

  Trang Thi Thuy Le, Thang Tat Nguyen, Chuyen Thi Hong Nguyen, Hao Trong Nguyen, Trung The Van

  27-10-2021

  https://doi.org/10.4081/dr.2021.9398

  3189

  PDF: 624

  HTML: 17
• 

  Two episodes of cutaneous non-tuberculous mycobacterial infection in a patient with psoriasis

  Wai Sze Agnes Chan, Shang-Ian Tee, Nisha Su Yien Chandran, Jiun Yit Pan

  15-06-2015

  https://doi.org/10.4081/dr.2015.5712

  2050

  PDF: 880

  HTML: 794
• 

  Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

  Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

  29-07-2021

  https://doi.org/10.4081/dr.2021.8797

  3176

  PDF: 672

  HTML: 22

• Survey on the management and patient satisfaction levels in individuals with psoriasis and/or psoriatic arthritis

  Nicoletta Bernardini, Giuseppe Paolo Antonio Gemma, Nevena Skroza, Giuseppe Rizzuto, Ersilia Tolino, Pietro Scribani Rossi, Antonio Ricupito, Ilaria Proietti, Annunziata Dattola, Concetta Potenza

  19-02-2026

  https://doi.org/10.4081/dr.2026.10788

  374

  PDF: 228

• Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

  Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris

  03-02-2026

  https://doi.org/10.4081/dr.2026.10644

  795

  PDF: 526

• Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

  Paolo Dapavo, Matteo Megna, Marina Talamonti

  09-08-2024

  https://doi.org/10.4081/dr.2024.9999

  1869

  PDF: 768

  HTML: 109

• Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

  Andrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, Chiara Assorgi, Annunziata Dattola, Viviana Lora, Matteo Megna, Flavia Pigliacelli, Emanuele Vagnozzi, Diego Orsini

  30-07-2025

  https://doi.org/10.4081/dr.2025.10379

  597

  PDF: 410

  HTML: 15
• 

  Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

  Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

  21-11-2022

  https://doi.org/10.4081/dr.2022.9265

  1586

  PDF: 476

  HTML: 38

• Health-related quality of life and clinical characteristics of hidradenitis suppurativa in a pediatric population

  Anna Dattolo, Francesca Sampogna, Simona Mastroeni, Luca Fania, Davide Ciccone, Damiano Abeni

  16-10-2024

  https://doi.org/10.4081/dr.2024.10086

  908

  PDF: 556

  HTML: 40

• Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

  Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

  01-07-2025

  https://doi.org/10.4081/dr.2025.10315

  642

  PDF: 332

  HTML: 26